Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study

Abstract Background Metaplastic breast cancer remains poorly characterized given its rarity and heterogeneity. The majority of metaplastic breast cancers demonstrate a phenotype of triple-negative breast cancer; however, differences in clinical outcomes between metaplastic breast cancer and triple-n...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Evan Morgan, Anupama Suresh, Akaansha Ganju, Daniel G. Stover, Robert Wesolowski, Sagar Sardesai, Anne Noonan, Raquel Reinbolt, Jeffrey VanDeusen, Nicole Williams, Mathew A. Cherian, Zaibo Li, Gregory Young, Marilly Palettas, Julie Stephens, Joseph Liu, Amanda Luff, Bhuvaneswari Ramaswamy, Maryam Lustberg
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2020-01-01
Rangatū:	World Journal of Surgical Oncology
Ngā marau:	Metaplastic breast cancer Clinical outcomes Distant disease-free survival Overall survival Triple-negative breast cancer Immune markers
Urunga tuihono:	https://doi.org/10.1186/s12957-019-1780-8
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!